Summary & Overview
HCPCS Q4123: Alloskin (allogeneic skin), per square centimeter
HCPCS Level II code Q4123 designates the application of Alloskin (allogeneic skin substitute) billed per square centimeter as an add-on service in addition to a primary procedure. This code is used when a clinician applies a biologic skin product to cover wounds, burns, or graft donor/recipient sites and must be appended separately to the claim. Nationally, skin substitute products are increasingly used in complex wound care and reconstructive procedures, making accurate coding important for clinical documentation and payment clarity.
Key payers considered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The analysis outlines coverage and billing considerations as they relate to product-specific add-on reporting, sites of service where the code is most often used, and common documentation elements required to support medical necessity.
Readers will find concise benchmarks for utilization patterns, a summary of relevant policy themes affecting skin substitute reimbursement, and clinical context on when an allogeneic skin product is typically used. Where payer-specific policies exist, the content highlights differences in coding practice and coverage language. Data not available in the input is noted where payer-specific rates, taxonomies, or diagnosis mappings would normally appear.
Billing Code Overview
HCPCS Level II code Q4123 represents Alloskin rt, billed per square centimeter as an add-on service to be listed separately in addition to a primary procedure. This code describes the use of an allogeneic skin substitute product applied to a wound or graft site and reported by area treated.
-
Service type: Skin substitute product application (allogeneic skin graft/substitute)
-
Typical site of service: Hospital outpatient departments, ambulatory surgical centers, wound care clinics, and other settings where surgical or procedural wound coverage is performed.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with a full-thickness or deep partial-thickness wound (for example after excision of necrotic tissue following trauma, burns, chronic non-healing ulcers, or surgical debridement of an infected graft site) requiring biologic skin substitute application. The patient is evaluated in an outpatient wound clinic or inpatient burn/trauma service. Initial steps include wound assessment, debridement/irrigation, hemostasis, and measurement of the wound area. Q4123 (Alloskin, per square centimeter) is applied as an adjunctive biologic skin replacement over the prepared wound bed to promote re-epithelialization and reduce fluid and protein loss.
The clinical workflow typically proceeds as follows: wound assessment and documentation of size and depth; informed consent; surgical or bedside debridement (if needed); preparation of the wound bed (hemostasis, control of infection); sizing/cutting and application of the Alloskin material; securement with appropriate dressings or grafting adjuncts; and post-procedure wound care instructions with scheduled follow-up visits for dressing changes and evaluation of graft take. Billing for Q4123 is reported per square centimeter as an add-on supply code in addition to a primary procedure code for the debridement, grafting, or wound repair.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Normal or routine service | Use when the procedure is performed under routine circumstances without unusual circumstances. |
22 | Increased procedural services | Use when work required to apply the biologic graft is substantially greater than typical (extensive debridement, prolonged operative time). |
52 | Reduced services | Use when the full described service was partially reduced or not completed (smaller area treated than planned). |
53 | Discontinued procedure | Use when the procedure was started but discontinued due to patient instability or unforeseen complication. |
54 | Surgical care only | Use when billing the surgeon for the operative portion separate from pre/post care billed by another provider. |
55 | Postoperative management only | Use when billing only for postoperative management (others billed the operation). |
62 | Two surgeons | Use when qualifying circumstances required two surgeons with distinct roles during the graft application. |
73 | Discontinued outpatient procedure prior to anesthesia | Use when the outpatient procedure was cancelled after prep but before anesthesia was given. |
78 | Return to operating room for related procedure during global period | Use when patient returns to OR for a related procedure on the same site during the global period. |
AS | Physician assistant, nurse practitioner, or clinical nurse specialist services for Medicare | Use when services are furnished by an advanced practice clinician under Medicare billing rules. |
CO | Workers' compensation (state/federal) | Use to indicate the claim is for a workers' compensation payor. |
CQ | Left-hand or lower extremity (supply-side) — HCPCS-specific use when required by payer | Use if payer requires laterality code for reporting supply application on a left extremity (payer policy dependent). |
QK | Medical direction of two, three, or four concurrent anesthesia procedures | Use when anesthesia medical direction meets these criteria for concurrent cases involving the procedure. |
QX | CRNA service with medical direction | Use when a certified registered nurse anesthetist provides services with physician medical direction. |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
207P00000X | Surgery - General Surgery | General surgeons frequently perform wound debridement and biologic graft application. |
363A00000X | Surgery - Plastic Surgery | Plastic surgeons commonly manage skin substitutes for reconstruction and burn care. |
282N00000X | Podiatry | Podiatrists apply skin substitutes for foot and lower-extremity ulcers. |
174400000X | Emergency Medicine | Emergency physicians may perform initial debridement and apply biologic dressings in acute settings. |
208200000X | Dermatology | Dermatologists manage complex wounds and apply skin substitutes for non-healing ulcers. |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
T31.0 | Burn of first degree of face (example) | Burns are a common indication for biologic skin substitute application after debridement to support healing. |
T31.1 | Burn of second degree of face (example) | Partial-thickness burns often benefit from biologic dressings to promote epithelialization. |
L97.309 | Non-pressure chronic ulcer of unspecified thigh, unspecified severity | Chronic non-healing lower-extremity ulcers are frequently treated with skin substitutes. |
L97.411 | Non-pressure chronic ulcer of right heel and midfoot with fat layer exposed | Deep chronic ulcers requiring biologic coverage to assist healing. |
S81.811A | Laceration without foreign body of right knee, initial encounter | Acute traumatic wounds after debridement may receive biologic graft application. |
I83.019 | Varicose veins of unspecified lower extremity with ulcer of unspecified site | Venous stasis ulcers commonly require advanced wound therapies including skin substitutes. |
A41.9 | Sepsis, unspecified organism | After control of infection and debridement, biologic dressings may be used as part of reconstructive care. |
Z48.00 | Encounter for surgical aftercare following unspecified procedure | Used for follow-up visits after application of skin substitute materials. |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
11042 | Debridement, skin, partial-thickness including epidermis and dermis; first 20 sq cm or less | Commonly performed before application of Q4123 to prepare a clean wound bed. |
11043 | Debridement, skin, full-thickness including subcutaneous tissue; first 20 sq cm or less | Used when deeper necrotic tissue requires removal prior to biologic graft placement. |
15271 | Application of skin substitute graft to trunk, arms, legs; first 100 sq cm or less, or per dressing | CPT for application of skin substitute materials; often billed alongside primary surgical codes when clinical documentation supports. |
15002 | Adjacent tissue transfer or rearrangement, first 30 sq cm or less of donor/recipient site (full-thickness grafting procedures) | Performed when local flap or grafting is needed in conjunction with biologic dressing. |
97597 | Debridement (selective) by enzymatic, sharp, mechanical, electrocautery, or laser; first 20 sq cm or less | Non-surgical debridement options in clinic prior to application of Q4123. |
12032 | Repair, intermediate wound (e.g., subcuticular sutures), face, ears, eyelids, nose, lips; 2.6 cm to 7.5 cm | Suturing or wound repair codes that may be billed when closure is performed in addition to biologic dressing application. |